Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Lebowitz's Stock Ratings
Citigroup Analyst
David Lebowitz is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
13.3%
Smart Score
Overall Average Return Percentile
65th
Number of Ratings
129
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/03/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | 5.32% | $69 → $84 | Maintains | Buy | Get Alert | |
| 09/02/2025 | CYTK | Buy Now | Cytokinetics | $64.34 | 30.56% | $77 → $84 | Maintains | Buy | Get Alert | |
| 08/22/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -13.49% | $65 → $69 | Maintains | Buy | Get Alert | |
| 08/20/2025 | CLDX | Buy Now | Celldex Therapeutics | $27.09 | 77.19% | $56 → $48 | Maintains | Buy | Get Alert | |
| 08/15/2025 | SDGR | Buy Now | Schrodinger | $18.10 | 10.5% | $35 → $20 | Downgrade | Buy → Neutral | Get Alert | |
| 08/08/2025 | ASND | Buy Now | Ascendis Pharma | $213.24 | 36% | $243 → $290 | Maintains | Buy | Get Alert | |
| 08/08/2025 | CYTK | Buy Now | Cytokinetics | $64.34 | 19.68% | $80 → $77 | Maintains | Buy | Get Alert | |
| 07/30/2025 | INCY | Buy Now | Incyte | $99.08 | 3.96% | $88 → $103 | Maintains | Buy | Get Alert | |
| 07/24/2025 | VKTX | Buy Now | Viking Therapeutics | $36.24 | 4.86% | $31 → $38 | Maintains | Neutral | Get Alert | |
| 07/18/2025 | COGT | Buy Now | Cogent Biosciences | $40.38 | -45.52% | $15 → $22 | Maintains | Buy | Get Alert | |
| 07/11/2025 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -9.34% | $58 → $67 | Maintains | Buy | Get Alert | |
| 07/11/2025 | ASND | Buy Now | Ascendis Pharma | $213.24 | 13.96% | $213 → $243 | Maintains | Buy | Get Alert | |
| 06/04/2025 | BPMC | Buy Now | Blueprint Medicines | — | — | $83 → $129 | Upgrade | Sell → Neutral | Get Alert | |
| 05/15/2025 | EXEL | Buy Now | Exelixis | $41.63 | 34.53% | $45 → $56 | Maintains | Buy | Get Alert | |
| 05/09/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 9.31% | $14 → $10 | Maintains | Neutral | Get Alert | |
| 05/07/2025 | CYTK | Buy Now | Cytokinetics | $64.34 | 24.34% | $86 → $80 | Maintains | Buy | Get Alert | |
| 03/04/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 18.11% | $4 → $1.5 | Maintains | Neutral | Get Alert | |
| 02/28/2025 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 53.04% | $12 → $14 | Maintains | Neutral | Get Alert | |
| 02/21/2025 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -33.69% | $45 → $49 | Maintains | Buy | Get Alert | |
| 02/20/2025 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -19.76% | $67 → $64 | Maintains | Buy | Get Alert | |
| 02/12/2025 | EXEL | Buy Now | Exelixis | $41.63 | 8.1% | $38 → $45 | Maintains | Buy | Get Alert | |
| 02/12/2025 | PTCT | Buy Now | PTC Therapeutics | $76.65 | -41.29% | $32 → $45 | Maintains | Sell | Get Alert | |
| 02/11/2025 | INCY | Buy Now | Incyte | $99.08 | -11.18% | $97 → $88 | Maintains | Buy | Get Alert | |
| 02/10/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 214.96% | $44 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 02/07/2025 | VKTX | Buy Now | Viking Therapeutics | $36.24 | 4.86% | → $38 | Initiates | → Neutral | Get Alert | |
| 02/07/2025 | CYTK | Buy Now | Cytokinetics | $64.34 | 33.67% | → $86 | Initiates | → Buy | Get Alert | |
| 12/04/2024 | PTCT | Buy Now | PTC Therapeutics | $76.65 | -58.25% | $26 → $32 | Maintains | Sell | Get Alert | |
| 11/13/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | 6.08% | $65 → $68 | Maintains | Buy | Get Alert | |
| 10/30/2024 | INCY | Buy Now | Incyte | $99.08 | -2.1% | $92 → $97 | Maintains | Buy | Get Alert | |
| 10/25/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 107.7% | $25 → $19 | Maintains | Neutral | Get Alert | |
| 10/07/2024 | CLDX | Buy Now | Celldex Therapeutics | $27.09 | 158.4% | → $70 | Initiates | → Buy | Get Alert | |
| 09/24/2024 | COGT | Buy Now | Cogent Biosciences | $40.38 | -62.85% | $13 → $15 | Maintains | Buy | Get Alert | |
| 09/17/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -2.93% | $178 → $207 | Maintains | Buy | Get Alert | |
| 09/04/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -16.53% | $193 → $178 | Maintains | Buy | Get Alert | |
| 08/02/2024 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -39.11% | $46 → $45 | Maintains | Buy | Get Alert | |
| 07/31/2024 | INCY | Buy Now | Incyte | $99.08 | -11.18% | $80 → $88 | Maintains | Buy | Get Alert | |
| 06/18/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | -0.16% | $38 → $64 | Maintains | Buy | Get Alert | |
| 05/21/2024 | PTCT | Buy Now | PTC Therapeutics | $76.65 | -66.08% | $18 → $26 | Maintains | Sell | Get Alert | |
| 05/10/2024 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 217.01% | $31 → $29 | Maintains | Neutral | Get Alert | |
| 05/07/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 3364.57% | $45 → $44 | Maintains | Buy | Get Alert | |
| 05/03/2024 | BPMC | Buy Now | Blueprint Medicines | — | — | $65 → $76 | Maintains | Sell | Get Alert | |
| 05/02/2024 | SDGR | Buy Now | Schrodinger | $18.10 | 104.42% | $39 → $37 | Maintains | Buy | Get Alert | |
| 03/06/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $560.55 | -31.85% | → $382 | Initiates | → Buy | Get Alert | |
| 03/01/2024 | SDGR | Buy Now | Schrodinger | $18.10 | 115.47% | $47 → $39 | Maintains | Buy | Get Alert | |
| 02/29/2024 | SDGR | Buy Now | Schrodinger | $18.10 | 115.47% | $47 → $39 | Maintains | Buy | Get Alert | |
| 02/26/2024 | COGT | Buy Now | Cogent Biosciences | $40.38 | -67.81% | $11 → $13 | Maintains | Buy | Get Alert | |
| 02/23/2024 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -37.75% | $42 → $46 | Maintains | Buy | Get Alert | |
| 02/16/2024 | BPMC | Buy Now | Blueprint Medicines | — | — | $54 → $65 | Maintains | Sell | Get Alert | |
| 02/14/2024 | INCY | Buy Now | Incyte | $99.08 | -18.25% | $82 → $81 | Maintains | Buy | Get Alert | |
| 02/08/2024 | ASND | Buy Now | Ascendis Pharma | $213.24 | -14.65% | $146 → $182 | Maintains | Buy | Get Alert | |
| 02/08/2024 | COGT | Buy Now | Cogent Biosciences | $40.38 | -72.76% | → $11 | Initiates | → Buy | Get Alert | |
| 12/15/2023 | EXEL | Buy Now | Exelixis | $41.63 | -25.53% | → $31 | Initiates | → Buy | Get Alert | |
| 11/07/2023 | BBIO | Buy Now | BridgeBio Pharma | $73.90 | -43.17% | → $42 | Initiates | → Buy | Get Alert | |
| 08/04/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 337.25% | $44 → $40 | Maintains | Neutral | Get Alert | |
| 07/31/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -24.77% | $36 → $60 | Upgrade | Neutral → Buy | Get Alert | |
| 07/25/2023 | INCY | Buy Now | Incyte | $99.08 | -17.24% | → $82 | Initiates | → Buy | Get Alert | |
| 06/30/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 83.8% | $103 → $96 | Maintains | Neutral | Get Alert | |
| 05/08/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 380.98% | $39 → $44 | Maintains | Neutral | Get Alert | |
| 05/08/2023 | SDGR | Buy Now | Schrodinger | $18.10 | 176.24% | $52 → $50 | Maintains | Buy | Get Alert | |
| 05/04/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -54.86% | $30 → $36 | Upgrade | Sell → Neutral | Get Alert | |
| 04/27/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 97.2% | $114 → $103 | Maintains | Neutral | Get Alert | |
| 04/05/2023 | ASND | Buy Now | Ascendis Pharma | $213.24 | -31.53% | $163 → $146 | Maintains | Buy | Get Alert | |
| 03/13/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 3837.01% | $55 → $50 | Maintains | Buy | Get Alert | |
| 02/21/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $52.23 | 122.09% | → $116 | Initiates | → Neutral | Get Alert | |
| 01/31/2023 | SDGR | Buy Now | Schrodinger | $18.10 | 181.77% | $48 → $51 | Maintains | Buy | Get Alert | |
| 01/24/2023 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 326.32% | $48 → $39 | Upgrade | Sell → Neutral | Get Alert | |
| 01/24/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 4230.71% | $36 → $55 | Maintains | Buy | Get Alert | |
| 11/10/2022 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | -46.96% | $38 → $34 | Maintains | Buy | Get Alert | |
| 11/10/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -61.13% | $28 → $31 | Maintains | Sell | Get Alert | |
| 11/03/2022 | ASND | Buy Now | Ascendis Pharma | $213.24 | -23.56% | $157 → $163 | Maintains | Buy | Get Alert | |
| 09/01/2022 | MIRM | Buy Now | Mirum Pharmaceuticals | $64.10 | -40.72% | → $38 | Initiates | → Buy | Get Alert | |
| 09/01/2022 | PTCT | Buy Now | PTC Therapeutics | $76.65 | -8.68% | → $70 | Initiates | → Buy | Get Alert | |
| 09/01/2022 | NTLA | Buy Now | Intellia Therapeutics | $9.15 | 446.57% | → $50 | Initiates | → Sell | Get Alert | |
| 09/01/2022 | PLRX | Buy Now | Pliant Therapeutics | $1.27 | 2734.65% | → $36 | Initiates | → Buy | Get Alert | |
| 08/10/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -64.89% | $26 → $28 | Maintains | Sell | Get Alert | |
| 07/15/2022 | IMRX | Buy Now | Immuneering | $5.83 | 105.83% | $18 → $12 | Maintains | Equal-Weight | Get Alert | |
| 07/15/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -58.11% | $170 → $164 | Maintains | Equal-Weight | Get Alert | |
| 06/10/2022 | BPMC | Buy Now | Blueprint Medicines | — | — | $68 → $41 | Downgrade | Neutral → Sell | Get Alert | |
| 06/07/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.40 | 32.65% | $36 → $39 | Maintains | Overweight | Get Alert | |
| 05/12/2022 | ASND | Buy Now | Ascendis Pharma | $213.24 | -25.91% | $187 → $158 | Maintains | Buy | Get Alert | |
| 05/10/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.40 | 22.45% | $37 → $36 | Maintains | Overweight | Get Alert | |
| 05/09/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -62.39% | $31 → $30 | Maintains | Underweight | Get Alert | |
| 04/29/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -46.1% | $223 → $211 | Maintains | Buy | Get Alert | |
| 04/13/2022 | BPMC | Buy Now | Blueprint Medicines | — | — | $71 → $68 | Maintains | Neutral | Get Alert | |
| 03/15/2022 | ASND | Buy Now | Ascendis Pharma | $213.24 | -7.62% | $180 → $197 | Maintains | Overweight | Get Alert | |
| 03/07/2022 | ASND | Buy Now | Ascendis Pharma | $213.24 | -15.59% | $197 → $180 | Maintains | Overweight | Get Alert | |
| 03/02/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.40 | 25.85% | $35 → $37 | Maintains | Overweight | Get Alert | |
| 03/01/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -43.04% | → $223 | Initiates | → Buy | Get Alert | |
| 03/01/2022 | SDGR | Buy Now | Schrodinger | $18.10 | 203.87% | → $55 | Initiates | → Buy | Get Alert | |
| 03/01/2022 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -67.4% | → $26 | Initiates | → Sell | Get Alert | |
| 03/01/2022 | BPMC | Buy Now | Blueprint Medicines | — | — | — | Initiates | → Neutral | Get Alert | |
| 03/01/2022 | ASND | Buy Now | Ascendis Pharma | $213.24 | -12.31% | → $187 | Initiates | → Buy | Get Alert | |
| 02/23/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -46.36% | $215 → $210 | Maintains | Overweight | Get Alert | |
| 01/18/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -45.08% | $226 → $215 | Maintains | Overweight | Get Alert | |
| 11/19/2021 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.40 | 19.05% | $50 → $35 | Maintains | Overweight | Get Alert | |
| 10/29/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -42.27% | $242 → $226 | Maintains | Overweight | Get Alert | |
| 10/12/2021 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 0.86% | $20 → $21 | Maintains | Equal-Weight | Get Alert | |
| 10/12/2021 | KPTI | Buy Now | Karyopharm Therapeutics | $6.71 | 302.38% | $29 → $27 | Maintains | Overweight | Get Alert | |
| 10/12/2021 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.54 | 295.48% | $13 → $14 | Maintains | Equal-Weight | Get Alert | |
| 10/12/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -61.13% | $33 → $31 | Maintains | Underweight | Get Alert | |
| 10/12/2021 | AVRO | Buy Now | Avrobio | — | — | $27 → $25 | Maintains | Overweight | Get Alert | |
| 10/12/2021 | ALNY | Buy Now | Alnylam Pharmaceuticals | $391.50 | -38.19% | $234 → $242 | Maintains | Overweight | Get Alert | |
| 09/01/2021 | SDGR | Buy Now | Schrodinger | $18.10 | 353.04% | → $82 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 08/26/2021 | ASND | Buy Now | Ascendis Pharma | $213.24 | -4.33% | $197 → $204 | Maintains | Overweight | Get Alert | |
| 08/24/2021 | IMRX | Buy Now | Immuneering | $5.83 | 568.95% | → $39 | Initiates | → Equal-Weight | Get Alert | |
| 08/10/2021 | EPZM | Buy Now | Epizyme | — | — | $10 → $5 | Downgrade | Equal-Weight → Underweight | Get Alert | |
| 07/16/2021 | IRWD | Buy Now | Ironwood Pharmaceuticals | $3.54 | 238.98% | $11 → $12 | Maintains | Equal-Weight | Get Alert | |
| 07/16/2021 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -58.63% | $35 → $33 | Maintains | Underweight | Get Alert | |
| 07/16/2021 | AVRO | Buy Now | Avrobio | — | — | $31 → $29 | Maintains | Overweight | Get Alert | |
| 07/16/2021 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.40 | 70.07% | $52 → $50 | Maintains | Overweight | Get Alert | |
| 06/14/2021 | ASND | Buy Now | Ascendis Pharma | $213.24 | -7.62% | $201 → $197 | Maintains | Overweight | Get Alert | |
| 05/28/2021 | ASND | Buy Now | Ascendis Pharma | $213.24 | -5.74% | $199 → $201 | Maintains | Overweight | Get Alert | |
| 05/27/2021 | ARQT | Buy Now | Arcutis Biotherapeutics | $29.40 | 76.87% | → $52 | Initiates | → Overweight | Get Alert | |
| 05/12/2021 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | -3.95% | $25 → $20 | Maintains | Equal-Weight | Get Alert | |
| 12/07/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 20.07% | $17 → $25 | Maintains | Equal-Weight | Get Alert | |
| 11/13/2020 | SDGR | Buy Now | Schrodinger | $18.10 | 391.71% | $90 → $89 | Maintains | Equal-Weight | Get Alert | |
| 11/09/2020 | EPZM | Buy Now | Epizyme | — | — | $29 → $27 | Maintains | Overweight | Get Alert | |
| 11/05/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -38.57% | $50 → $49 | Maintains | Underweight | Get Alert | |
| 11/04/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | -18.35% | $16 → $17 | Maintains | Equal-Weight | Get Alert | |
| 10/13/2020 | SDGR | Buy Now | Schrodinger | $18.10 | 397.24% | $93 → $90 | Maintains | Equal-Weight | Get Alert | |
| 10/13/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -37.31% | $54 → $50 | Maintains | Underweight | Get Alert | |
| 08/06/2020 | IONS | Buy Now | Ionis Pharmaceuticals | $79.76 | -32.3% | $56 → $54 | Maintains | Underweight | Get Alert | |
| 06/01/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | -23.16% | $22 → $16 | Maintains | Equal-Weight | Get Alert | |
| 05/29/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | -23.16% | $22 → $16 | Maintains | Equal-Weight | Get Alert | |
| 05/21/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 5.66% | $10 → $22 | Maintains | Equal-Weight | Get Alert | |
| 03/11/2020 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | -51.97% | $8 → $10 | Maintains | Equal-Weight | Get Alert | |
| 10/29/2018 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | — | — | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 03/14/2018 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 15.26% | $25 → $24 | Maintains | Overweight | Get Alert | |
| 03/28/2016 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 5.66% | → $22 | Initiates | → Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved